Quantitative chest X-ray radiomics for therapy response monitoring in patients with pulmonary tuberculosis
dc.contributor.author | Du Plessis, Tamarisk | |
dc.contributor.author | Rae, William Ian Duncombe | |
dc.contributor.author | Ramkilawon, Gopika Devi | |
dc.contributor.author | Ramkilawon, Gopika Devi | |
dc.contributor.author | Martinson, Neil Alexander | |
dc.contributor.author | Sathekge, Mike Machaba | |
dc.date.accessioned | 2024-05-15T12:16:40Z | |
dc.date.available | 2024-05-15T12:16:40Z | |
dc.date.issued | 2023-09-01 | |
dc.description | DATA AVAILABILITY STATEMENT : Data are available on request from the corresponding author. | en_US |
dc.description.abstract | Tuberculosis (TB) remains the second leading cause of death globally from a single infectious agent, and there is a critical need to develop improved imaging biomarkers and aid rapid assessments of responses to therapy. We aimed to utilize radiomics, a rapidly developing image analysis tool, to develop a scoring system for this purpose. A chest X-ray radiomics score (RadScore) was developed by implementing a unique segmentation method, followed by feature extraction and parameter map construction. Signature parameter maps that showed a high correlation to lung pathology were consolidated into four frequency bins to obtain the RadScore. A clinical score (TBscore) and a radiological score (RLscore) were also developed based on existing scoring algorithms. The correlation between the change in the three scores, calculated from serial X-rays taken while patients received TB therapy, was evaluated using Spearman’s correlation. Poor correlations were observed between the changes in the TBscore and the RLscore (0.09 (p-value = 0.36)) and the TBscore and the RadScore (0.02 (p-value = 0.86)). The changes in the RLscore and the RadScore had a much stronger correlation of 0.22, which is statistically significant (p-value = 0.02). This shows that the developed RadScore has the potential to be a quantitative monitoring tool for responses to therapy. | en_US |
dc.description.department | Nuclear Medicine | en_US |
dc.description.department | Statistics | en_US |
dc.description.librarian | am2024 | en_US |
dc.description.sdg | SDG-03:Good heatlh and well-being | en_US |
dc.description.sponsorship | FUNDING : The APC was funded by the Department of Nuclear Medicine, University of Pretoria, South Africa. | en_US |
dc.description.uri | https://www.mdpi.com/journal/diagnostics | en_US |
dc.identifier.citation | Du Plessis, T.; Rae, W.I.D.; Ramkilawon, G.; Martinson, N.A.; Sathekge, M.M. Quantitative Chest X-ray Radiomics for Therapy Response Monitoring in Patients with Pulmonary Tuberculosis. Diagnostics 2023, 13, 2842. https://DOI.org/10.3390/diagnostics13172842. | en_US |
dc.identifier.issn | 2075-4418 (online) | |
dc.identifier.other | 10.3390/diagnostics13172842 | |
dc.identifier.uri | http://hdl.handle.net/2263/95995 | |
dc.language.iso | en | en_US |
dc.publisher | MDPI | en_US |
dc.rights | © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. | en_US |
dc.subject | Radiomics | en_US |
dc.subject | Segmentation | en_US |
dc.subject | Feature extraction | en_US |
dc.subject | Chest X-rays | en_US |
dc.subject | Radiomics score | en_US |
dc.subject | Tuberculosis (TB) | en_US |
dc.subject | SDG-03: Good health and well-being | en_US |
dc.title | Quantitative chest X-ray radiomics for therapy response monitoring in patients with pulmonary tuberculosis | en_US |
dc.type | Article | en_US |